Luis Gil Abinader, @abinader.bsky.social retweetledi
A must read: Abolishing USAID Is Both Unconstitutional and Disastrous
foreignpolicy.com/2025/02/04/usa…
@MMKavanagh @abinader
English
Luis Gil Abinader, @abinader.bsky.social
9.1K posts
Luis Gil Abinader, @abinader.bsky.social
@abinader
law, technology, policy.
Washington, DC Katılım Ekim 2008
1.3K Takip Edilen1.8K Takipçiler
Luis Gil Abinader, @abinader.bsky.social retweetledi
New on #USAID: First, in @ForeignPolicy our piece on illegality of abolishing USAID. To be clear-eyed: This is neither good policy nor legal under the most basic elements of U.S. law and the Constitution.
w @abinader
And you can also read our memo...
foreignpolicy.com/2025/02/04/usa…
English
Luis Gil Abinader, @abinader.bsky.social retweetledi
🛑Closing down USAID is illegal.
📜It's an independent agency with authorities legislated by Congress.
⚠️The president has no legal authority to abolish or move it under the State Department unilaterally
Strong analysis by @MMKavanagh & @abinader.
👇🏼
bit.ly/4i2jeAH
English
Luis Gil Abinader, @abinader.bsky.social retweetledi
👉MPP’s Expert Advisory Group meet in Geneva to provide critical guidance on our work. This group of experts in regulatory, IP law, public health, R&D, and more play a vital role in helping expand access to essential medicines worldwide. 🌍💊#AccessToMedicines
English
Luis Gil Abinader, @abinader.bsky.social retweetledi
Excited to be meeting our 2025 @GeorgetownLaw health law LL.M. with @oneillinstitute in person! Thanks also to our amazing alumni for giving back to our new students. #HoyaHealthLawya!
English
Luis Gil Abinader, @abinader.bsky.social retweetledi
Mylan’s legal fees for patent litigation:
2012: $46,158,403
2013: $38,211,911
2014: $38,618,993
If you want to launch a generic or biosimilar, be prepared to sink tens of millions of $ into legal fees to cut through patent thickets.
English
Luis Gil Abinader, @abinader.bsky.social retweetledi
Good @TheLancet piece on the Pharmaceutical Accountability Foundation’s @StichtingFTV legal case against @abbvie for its excessive pricing of Humira thelancet.com/action/showPdf…
English
Luis Gil Abinader, @abinader.bsky.social retweetledi
In 2019, Kamala Harris proposed the use of march-in rights to bring down drug prices.
English
Luis Gil Abinader, @abinader.bsky.social retweetledi
Students in my clinic—the Science, Health & Information Clinic @ColumbiaLaw—represented @EFF in this motion, as part of a long-running partnership to protect the public's right to access evidence & arguments in patent & other "tech law" cases.
Next stop: the Federal Circuit!
EFF@EFF
We’re appealing a court order to fight for greater transparency in patent disputes. eff.org/deeplinks/2024…
English
Luis Gil Abinader, @abinader.bsky.social retweetledi
📰The US is nearing an agreement to bankroll a late-stage trial of Moderna’s mRNA pandemic bird flu vaccine.
💉It would be good to understand what, if any, access provisions are included in this deal.
Important @FT story. Thanks for breaking it @mroliverbarnes.
ft.com/content/fad59e…
English
Luis Gil Abinader, @abinader.bsky.social retweetledi
.@moderna_tx tried to extract a huge price for its #COVID-19 #vaccine from the South African government at the height of the pandemic, according to the local NGO @HealthJusticeIn, in revelations made public this week.
✍ @kerrycullinan11
healthpolicy-watch.news/modernas-attem…
English
Luis Gil Abinader, @abinader.bsky.social retweetledi
Comments accepted until July 22! Make your voice heard!
English
Professor @rai_arti on march-in rights.
Duke Law@DukeLaw
WATCH | Today at 10AM: Prof. Arti Rai (@rai_arti), a patent law and policy expert, is speaking at the Senate Committee on the Judiciary’s hearing on “Ensuring Affordable & Accessible Medications: Examining Competition in the Prescription Drug Market.” judiciary.senate.gov/committee-acti…
English
Interesting to see South African government officials citing the WHA transparency resolution to advocate against secrecy during their negotiations with Pfizer.
International norms can either deprive or empower government officials with more leverage to protect public interests.
Matthew Kavanagh [email protected]@MMKavanagh
Today we join @HealthJusticeIn in report showing Moderna & Pfizer wielded unprecedented power in COVID-19 negotiations w South Africa. The SA govt tried to include transparency, supply commitment, etc to realize its obligations under SA and Intl law. Was blocked by monopoly power
English
Luis Gil Abinader, @abinader.bsky.social retweetledi
Today we join @HealthJusticeIn in report showing Moderna & Pfizer wielded unprecedented power in COVID-19 negotiations w South Africa. The SA govt tried to include transparency, supply commitment, etc to realize its obligations under SA and Intl law. Was blocked by monopoly power
Health Justice Initiative - HJI@HealthJusticeIn
Breaking:⏰📢 'Groundbreaking Access to Documents Show Pharma Giants Bullied SA in Covid-19 Vaccine Negotiations' Records & Analysis “The Negotiations, One Sided-Part 2’’ with @Public_Citizen @oneillinstitute is publicly available at: healthjusticeinitiative.org.za/pandemic-trans… @peoplesvaccine
English
Luis Gil Abinader, @abinader.bsky.social retweetledi
Breaking:⏰📢
'Groundbreaking Access to Documents Show Pharma Giants Bullied SA in Covid-19 Vaccine Negotiations'
Records & Analysis “The Negotiations, One Sided-Part 2’’ with @Public_Citizen @oneillinstitute is publicly available at:
healthjusticeinitiative.org.za/pandemic-trans…
@peoplesvaccine
English
Balasubramaniam@ThiruGeneva
Sanctions for Non Disclosure, as Set Out in Article 6 of the @WIPO Basic Proposal on Intellectual Property, Genetic Resources and Traditional Knowledge, Should Include Possible Revocation of a Patent infojustice.org/archives/45747 Timely piece by @jamie_love and @clairecassedy
ZXX
Luis Gil Abinader, @abinader.bsky.social retweetledi
Documents: New pandemic deal texts circulated ahead of Fridayʼs deadline pro.politico.eu/news/179589
English
Luis Gil Abinader, @abinader.bsky.social retweetledi
1. One way pharma companies block competition and inflate the cost of medicines is by filing bogus patent listings.
Today @FTC challenged over 300 junk patent listings, including for blockbuster weight-loss & type 2 diabetes drugs Ozempic and Victoza.
ftc.gov/news-events/ne…
English
Luis Gil Abinader, @abinader.bsky.social retweetledi
The top 20 pharma companies by 2023 revenue fiercepharma.com/pharma/top-20-…
English